| Literature DB >> 36117813 |
Elpiniki Lagouvardou1, Gennaro Martines2, Giovanni Tomasicchio2, Rita Laforgia1, Angela Pezzolla2, Onofrio Caputi Iambrenghi2.
Abstract
Introduction: The management of chole-choledocholithiasis remains a matter of debate to preserve minimal invasive management and different options have been proposed, with single- or two-stage approaches. Two techniques of single-stage approach are intraoperative ERCP and laparoscopic rendezvous, which have the great advantage of reducing the length of hospital stay with increased patient compliance. This retrospective study aims to evaluate and compare the efficacy and safety of intraoperative ERCP and rendezvous technique for more than 15 years. Materials and methods: Clinical records of 113 patients who underwent single-stage management for chole-choledocholithiasis between January 2003 and December 2020 were retrospectively reviewed using a prospectively maintained database. Patients were separated into two groups: those managed with intraoperative ERCP and those with rendezvous, and their intraoperative and postoperative parameters were compared. All patients were followed up for 6 months in an outpatient setting.Entities:
Keywords: ERCP; chole-choledocholithiasis; outcomes; rendezvous; single-stage approach
Year: 2022 PMID: 36117813 PMCID: PMC9470774 DOI: 10.3389/fsurg.2022.938962
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Relationship between demographic features and comorbidities of intraoperative ERCP and rendezvous groups.
| Demographic data | |||
|---|---|---|---|
| Intraoperative ERCP | Rendezvous | ||
| Age | 68 | 59 | 0.65 |
| (Years) | (62–74) | (53–66) | |
| Gender (M/F) | 31/37 | 23/22 | 0.83 |
| ASA | |||
| – I | 11 (16.2%) | 9 (20%) | 0.78 |
| – II | 35 (51.4%) | 21 (46.7%) | 0.75 |
| – III | 22 (32.4%) | 15 (33.3%) | 1 |
| – IV | 0 | 0 | – |
| Comorbidity | |||
| – Cardiovascular | 30 (44.2%) | 20 (44.4%) | 1 |
| – Diabetes | 16 (23.6%) | 9 (20%) | 0.83 |
| – Respiratory | 11 (16.2%) | 7 (15.6%) | 1 |
ERCP, endoscopic retrograde cholangiopancreatography.
Relationship between intraoperative data of intraoperative ERCP and rendezvous groups.
| Intraoperative data | |||
|---|---|---|---|
| Intraoperative ERCP | Rendezvous | ||
| Operative time | |||
| – Total time (min) | 145 (104–168) | 120 (94–147) | *<0.05 |
| – Endoscopic time (min) | 27 (15–36) | 15 (12–22) | *<0.05 |
*statistically significant.
ERCP, endoscopic retrograde cholangiopancreatography.
Overall morbidity and specific complications of intraoperative ERCP and rendezvous groups.
| Postoperative data | |||
|---|---|---|---|
| Intraoperative ERCP | Rendezvous | ||
| Hospital stay | 4 (3–5) | 3 (2–4) | <0.05* |
| Readmission <30 days | 0 | 0 | — |
| Complications | |||
| – Bleeding | 3 (4.2%) | 0 | 0.27 |
| – Pancreatitis | 9 (13%) | 1 (2.2%) | <0.05* |
| – Bile leak | 0 | 1 (2.2%) | 0.3 |
| – Cholangitis | 1 (1.4%) | 0 | 1 |
| – Abscess | 1 (1.4%) | 0 | 1 |
| Clavein–Dindo | |||
| – 0 | 53 (78%) | 43 (95.5%) | <0.05* |
| – I | 9 (13%) | 2 (4.5%) | 0.19 |
| – II | 4 (6%) | 0 | 0.14 |
| – IIIa | 2 (3%) | 0 | 0.5 |
| – IIIb | 0 | 0 | — |
| Later biliary complications | |||
| – Biliary/papillary stenosis | 1 (1.4%) | 0 | 1 |
| – Recurrence CBD stones | 1 (1.4%) | 0 | 1 |
*statistically significant.
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography.